These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3118265)

  • 21. Haemofiltration or haemodialysis in aluminium elimination?
    Sulkova S; Laurincova Z; Válek A
    Nephrol Dial Transplant; 1991; 6 Suppl 3():3-5. PubMed ID: 1775263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.
    Ciancioni C; Poignet JL; Mauras Y; Panthier G; Delons S; Allain P; Man NK
    Trans Am Soc Artif Intern Organs; 1984; 30():479-82. PubMed ID: 6533925
    [No Abstract]   [Full Text] [Related]  

  • 24. Desferrioxamine improves burst-forming unit-erythroid (BFU-E) proliferation in haemodialysis patients.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Crisetti A; Modoni S; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1998 May; 13(5):1194-9. PubMed ID: 9623553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T; Ferro G; Frontini V; Percolla S
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
    J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S; Lynn RI
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of long-term and low-dose desferrioxamine therapy against hyperaluminemia and the clinical symptoms associated with hyperaluminemia in patients undergoing maintenance hemodialysis].
    Kuramochi G
    Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):267-73. PubMed ID: 2739124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common.
    Roger SD; Stewart JH; Harris DC
    Nephron; 1991; 58(1):33-6. PubMed ID: 1857480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
    Labonia W; Rubio D; Arias C
    Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
    G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    McCauley J; Sorkin MI
    Nephrol Dial Transplant; 1989; 4(2):110-4. PubMed ID: 2496351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
    Roodhooft AM; van de Vyver FL; D'Haese PC; van Acker KJ; Visser WJ; de Broe ME
    Clin Nephrol; 1987 Sep; 28(3):125-9. PubMed ID: 3665205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
    Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
    Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
    Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
    Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Speech apraxia in dialysis-associated aluminum encephalopathy].
    Haug BA; Botsch G; Felgenhauer K
    Nervenarzt; 1991 Oct; 62(10):637-40. PubMed ID: 1749454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.